This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Brain, infratentorial
CD2_BENIGN_BRAIN_INFRATENT_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D33
- Name in latin
- Neoplasma benignum cerebri infratentoriale
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Brain, infratentorial
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Brain, infratentorial
- Benign neoplasm of brain and other parts of central nervous system
- Benign neoplasm of brain and other parts of central nervous system
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 208 | 126 | 82 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.04 |
| Median age at first event (years) | 47.97 | 46.83 | 49.72 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 185
- Matched controls
- 1848
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
1021.4
112.6
99
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
31.6
75.1
106
75
D33.10
ICD-10 Finland
Benign pilosytic astrocytoma of brain stem
+∞
64.4
58
*
D33.14
ICD-10 Finland
Hemangioblastoma and cerebellum
+∞
55.0
50
*
9161/1-C71.6
ICD-O-3
Hemangioblastoma of cerebellum, NOS
+∞
41.2
38
*
D33.15
ICD-10 Finland
Another benign tumor of the cerebellum
+∞
40.1
37
*
H02AB02
ATC
dexamethasone; systemic
49.0
37.7
45
12
D33.11
ICD-10 Finland
Brain stem
+∞
36.7
34
*
D33.12
ICD-10 Finland
Cerebellum
+∞
32.2
30
*
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
192.1
31.8
32
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
27.1
28.4
39
18
C71.60
ICD-10 Finland
Malignant tumor of cerebellum without histology
+∞
27.8
26
*
D43.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, infratentorial
314.2
27.5
27
*
D33.1
ICD-10 Finland
Benign neoplasm: Brain, infratentorial
+∞
21.2
20
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
6.0
20.6
65
153
130
Kela drug reimbursment
Malignant tumour
+∞
20.2
19
*
G91.1
ICD-10 Finland
Obstructive hydrocephalus
+∞
19.1
18
*
9421/1-C71.6
ICD-O-3
Pilocytic astrocytoma of cerebellum, NOS
+∞
18.0
17
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
7.1
18.0
47
85
AA1AD
NOMESCO Finland
CT of head and brain
4.0
14.7
71
249
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
58.0
14.0
16
*
D33.00
ICD-10 Finland
Medial pilosytic astrocytoma of the cerebrum
+∞
13.7
13
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.7
13.2
72
274
R51.80
ICD-10 Finland
Headache
4.3
12.9
54
163
D33.17
ICD-10 Finland
Fourth ventricle
+∞
12.6
12
*
WF002
NOMESCO Finland
Radical radiotherapy
+∞
12.6
12
*
XA800
NOMESCO Finland
Neuropsychological investigation
9.3
12.6
26
32
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
11.7
12.1
22
21
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.8
12.1
58
197
A04AA02
ATC
granisetron; systemic, transdermal
+∞
11.6
11
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.7
11.1
54
184
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
23.2
10.9
15
7
ABB00
NOMESCO Finland
Excision of lesion of spinal canal
63.8
10.8
12
*
AAF00
NOMESCO Finland
Ventriculostomy
63.8
10.8
12
*
H53.2
ICD-10 Finland
Diplopia
9.7
10.6
21
24
D33.9
ICD-10 Finland
Benign neoplasm: Central nervous system, unspecified
+∞
10.5
10
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
10.5
10
*
XCK00
NOMESCO Finland
Perimetry
6.9
10.1
25
41
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
9.5
9
*
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
+∞
9.5
9
*
G91.0
ICD-10 Finland
Communicating hydrocephalus
+∞
9.5
9
*
D33.42
ICD-10 Finland
Hemangioblastoma of the spinal cord
+∞
9.5
9
*
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
+∞
9.5
9
*
A03FA01
ATC
metoclopramide; systemic, rectal
3.8
9.2
41
129
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
17.3
8.7
13
8
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
29.1
8.6
11
*
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
94.2
8.5
9
*
Q85.82
ICD-10 Finland
of Hipple-Lindau syndrome
+∞
8.4
8
*
D43.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, unspecified
+∞
8.4
8
*
R4110
NOMESCO Finland
Physiotherapy
2.8
8.3
61
273
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
26.3
7.7
10
*
A04AA01
ATC
ondansetron; systemic, rectal
8.2
7.6
16
21
AA1BD
NOMESCO Finland
Extensive CT of head and brain
14.1
7.5
12
9
D32.05
ICD-10 Finland
Cerebral meninges
+∞
7.3
7
*
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
+∞
7.3
7
*
XCW99
NOMESCO Finland
Other investigative procedure of eye
3.8
7.2
31
94
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
31.4
7.2
9
*
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
31.4
7.2
9
*
WX882
NOMESCO Finland
High dependency care
8.1
7.1
15
20
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
11.6
6.9
12
11
WX110
NOMESCO Finland
Local anesthesy
2.3
6.6
135
989
TAB00
NOMESCO Finland
Lumbar puncture
5.6
6.5
18
35
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
72.2
6.5
7
*
D33.30
ICD-10 Finland
Acoustic neuroma
72.2
6.5
7
*
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
4.4
6.4
22
55
H55
ICD-10 Finland
Nystagmus and other irregular eye movements
+∞
6.3
6
*
C71.00
ICD-10 Finland
Malignant tumor of the cerebrum except lobes and ventricles without histology
+∞
6.3
6
*
N76
ICPC
Neoplasm nervous system unspecified
+∞
6.3
6
*
9380/3-C71.9
ICD-O-3
Glioma, malignant of brain, NOS
+∞
6.3
6
*
AAF50
NOMESCO Finland
Third ventriculostomy
+∞
6.3
6
*
C71.6
ICD-10 Finland
Malignant neoplasm: Cerebellum
+∞
6.3
6
*
C71.69
ICD-10 Finland
Malignant tumor of the cerebellum other or unspecified histology
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
29
8
41.79
23.70
2.2
2.1
—
—
—
0
0
54
135
5.05
21.07
7.1
11.1
0.7
1.5
mmol/l
0.79
41
109
20
16
13.72
20.61
3.3
1.3
—
—
—
0
0
126
647
3.40
16.69
7.3
6.3
1.2
1.2
mmol/l
1.85
118
585
129
716
3.11
14.17
5.7
6.5
1.2
1.2
mmol/l
1.40
116
636
77
329
3.13
13.31
2.6
2.1
—
—
—
0
0
39
108
4.21
13.05
5.7
7.9
24.0
24.9
mmol/l
1.09
39
108
17
7
26.27
12.68
4.2
1.4
1.4
3.7
nmol/l
—
17
7
31
76
4.62
12.08
7.9
10.0
0.7
0.7
%
0.31
31
76
31
76
4.62
12.08
7.7
10.1
0.9
1.4
%
3.15
31
76
147
929
2.99
11.88
6.1
4.7
6.4
6.6
mmol/l
0.49
142
843
115
662
2.65
10.79
3.7
3.8
—
—
—
0
0
20
40
5.43
9.79
2.3
1.2
24.3
3.3
e6/l
0.62
13
33
20
40
5.43
9.79
2.5
1.3
95.7
799.5
e6/l
0.88
13
35
14
9
16.56
9.17
2.8
1.2
—
—
—
0
0
97
598
2.17
6.86
4.0
4.4
36.6
36.2
g/l
0.32
88
560
110
750
1.99
5.59
5.7
4.1
10.4
12.7
umol/l
1.40
101
699
75
481
1.87
4.31
3.8
2.1
2.4
2.3
mmol/l
0.39
61
401
80
528
1.84
4.18
3.4
3.0
—
—
—
0
0
84
578
1.76
3.73
2.9
3.5
17.8
100.0
ng/l
0.66
50
361
39
211
2.04
3.63
1.9
4.4
0.8
0.8
mmol/l
0.24
34
199
63
402
1.81
3.59
2.0
2.2
3.3
2.8
mg/l
0.73
52
352
47
278
1.89
3.38
1.9
1.6
942.2
1176.2
nmol/l
0.92
37
209
64
426
1.73
3.11
3.6
2.9
0.2
0.4
e6/l
1.01
52
310
43
257
1.85
2.98
3.1
2.7
0.7
1.1
e6/l
0.51
30
136
43
258
1.84
2.95
2.9
1.9
2.4
2.4
mmol/l
0.57
36
210
7
16
4.49
2.49
1.3
1.1
—
—
—
0
0
38
236
1.75
2.32
3.5
3.0
2.9
3.0
e6/l
0.01
24
116
34
205
1.79
2.29
1.5
1.7
—
—
—
0
0
65
467
1.57
2.26
2.0
2.2
52.3
54.8
u/l
0.35
60
435
5
9
5.66
2.22
1.2
1.1
—
—
—
0
0
31
185
1.79
2.16
5.4
7.0
—
—
—
0
0
141
1204
1.53
2.15
7.1
5.1
77.2
78.3
u/l
0.14
133
1104
25
143
1.85
2.00
1.5
1.5
—
—
—
0
0
5
11
4.63
1.95
1.2
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
12
4.24
1.83
1.4
1.2
—
—
—
0
0
24
143
1.77
1.70
1.5
1.6
—
—
—
0
0
14
70
2.07
1.63
1.6
1.6
263.4
335.0
mu/l
0.56
14
64
184
1705
1.69
1.62
16.7
10.9
21.5
20.8
mg/l
0.13
162
1287
169
1537
1.53
1.60
13.4
9.4
89.0
85.0
ml/min/173m2
1.61
146
1214
94
771
1.40
1.59
2.5
2.8
129.8
92.9
ug/l
0.70
86
717
85
687
1.40
1.56
2.6
2.5
73.9
75.3
nmol/l
0.17
78
618
33
227
1.54
1.37
2.8
2.5
1.0
0.7
ug/l
0.88
21
140
147
1322
1.38
1.31
4.3
3.9
14.6
14.7
pmol/l
0.13
134
1205
157
1688
0.71
1.22
4.8
4.7
2.8
2.8
mmol/l
0.39
145
1567
77
634
1.34
1.21
2.3
1.9
98.5
96.4
pmol/l
0.13
47
303
18
110
1.70
1.20
3.6
1.7
72.8
67.9
ml/min/173m2
—
5
42
109
945
1.32
1.19
7.2
6.5
4.2
4.1
e9/l
0.15
93
818
155
1667
0.72
1.17
4.2
4.3
4.7
4.7
mmol/l
0.49
142
1555
7
30
2.38
1.13
1.1
1.2
—
—
—
0
0
7
31
2.30
1.11
1.0
2.0
—
—
—
0
0
154
1654
0.73
1.11
4.2
4.3
1.5
1.5
mmol/l
0.00
142
1538
10
172
0.56
0.98
1.2
1.7
—
—
—
0
0
10
54
1.89
0.98
1.4
1.7
—
—
—
0
0
27
193
1.46
0.96
4.0
4.3
31.2
32.1
%
0.17
19
128
41
318
1.36
0.94
1.7
1.7
447.2
457.9
pmol/l
0.09
33
267
12
71
1.73
0.91
1.8
1.3
—
—
—
0
0
41
322
1.34
0.87
3.8
3.5
22.0
24.3
%
0.52
21
142
5
24
2.11
0.75
1.2
1.0
—
—
—
0
0
5
24
2.11
0.75
1.2
1.0
—
—
—
0
0
168
1590
1.29
0.73
5.3
4.6
1.7
2.6
mu/l
0.65
155
1461
46
377
1.28
0.73
3.6
3.5
1.0
1.0
kg/l
0.00
11
52
89
789
1.22
0.71
3.8
3.5
0.0
0.0
estimate
0.00
11
143
5
27
1.87
0.69
4.0
3.9
385.0
370.6
umol/l
—
5
22
14
95
1.51
0.66
1.2
1.4
—
—
—
0
0
5
30
1.68
0.62
1.2
1.5
—
—
—
0
0
8
52
1.56
0.60
2.0
1.8
—
—
—
0
0
8
54
1.50
0.58
1.9
1.9
—
—
—
0
0
113
1217
0.84
0.56
3.1
3.3
—
—
—
0
0
18
134
1.38
0.55
1.6
2.7
215.2
226.8
u/l
0.31
18
128
9
62
1.47
0.54
1.0
1.2
—
—
—
0
0
7
106
0.65
0.50
1.1
1.0
—
—
—
0
0
17
128
1.36
0.49
3.1
3.1
—
—
—
0
0
16
122
1.34
0.44
3.9
4.4
2.4
1.5
mmol/l
0.38
11
79
87
799
1.15
0.43
5.7
4.8
0.0
0.0
estimate
0.00
11
143
168
1620
1.19
0.42
17.2
12.2
40.0
40.5
%
0.41
124
1251
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
34
290
1.21
0.40
3.6
3.7
43.6
277.2
ng/l
1.22
23
214
31
361
0.83
0.37
1.8
1.8
0.7
0.9
mg/l
0.83
25
271
5
37
1.36
0.37
3.2
3.6
—
—
—
0
0
11
81
1.38
0.37
1.6
1.3
—
—
—
0
0
131
1249
1.13
0.34
3.9
3.8
11.4
10.4
mm/h
0.32
120
1150
6
45
1.34
0.34
1.5
1.3
—
—
—
0
0
44
392
1.16
0.32
2.1
3.1
436.7
1133.9
ng/l
1.97
35
320
7
96
0.72
0.31
1.9
1.4
—
—
—
0
0
33
288
1.17
0.31
1.3
1.4
—
—
—
0
0
7
54
1.31
0.30
1.1
1.3
—
—
—
0
0
154
1588
0.88
0.29
3.7
3.9
1.3
1.3
mmol/l
0.06
141
1467
46
416
1.14
0.28
3.8
3.7
0.0
0.0
estimate
—
10
139
9
72
1.26
0.26
1.3
2.0
—
—
—
0
0
86
811
1.10
0.26
4.2
3.5
0.0
0.0
estimate
0.00
11
140
67
628
1.10
0.22
3.9
3.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
1.0
—
0
6
0
13
0.00
0.21
0.0
2.5
—
717.5
—
0
13
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
0
14
0.00
0.20
0.0
1.9
—
—
—
0
0
7
62
1.13
0.17
1.0
1.2
—
—
—
0
0
36
389
0.91
0.16
1.9
2.2
316.9
6859.8
umol/l
1.82
30
338
150
1530
0.93
0.15
5.5
5.5
37.3
39.2
mmol/mol
2.32
140
1441
113
1158
0.95
0.12
3.7
3.1
50.2
41.4
u/l
0.58
105
1098
13
147
0.88
0.12
2.4
2.0
—
—
—
0
0
5
44
1.14
0.10
1.0
1.1
—
23.5
—
0
7
11
123
0.89
0.08
1.8
1.3
—
50.3
—
0
10
7
68
1.03
0.08
1.7
1.6
—
—
—
0
0
38
396
0.95
0.07
1.8
1.6
—
—
—
0
0
28
294
0.94
0.06
2.5
2.3
—
—
—
0
0
162
1633
0.96
0.04
4.4
4.1
5.6
5.8
mmol/l
2.26
150
1491
26
270
0.96
0.03
2.3
2.2
—
—
—
0
0
183
1839
0.96
0.03
10.0
8.1
25.8
25.5
u/l
0.10
176
1767
13
122
1.07
0.02
2.0
1.9
—
—
—
0
0
44
432
1.02
0.01
1.2
1.4
5.6
1.4
u/ml
0.45
12
113
30
294
1.02
0.00
1.3
1.3
11.5
25.6
iu/ml
—
10
105
28
279
1.00
0.00
1.4
1.3
9.4
7.3
u/ml
0.11
13
112
10
105
0.95
0.00
1.0
1.4
—
—
—
0
0
0
8
0.00
0.00
0.0
2.3
—
156.0
—
0
8
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
1.0
—
109.2
—
0
6
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
6
65
0.92
0.00
1.2
2.4
—
—
—
0
0
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
5
54
0.92
0.00
1.4
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
118.0
—
0
5
0
5
0.00
0.00
0.0
1.0
—
7.8
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_BRAIN_INFRATENT_EXALLC – Benign neoplasm: Brain, infratentorial
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).